Boustead Securities
- Dec 15, 2016
- 0 min read

Dan McClory discusses whether the Fed’s interest rate hike will impact China

Recent Posts

Boustead IPO Client Blue Water Vaccines ("BWV") Announces Closing of Initial Public Offering

Boustead IPO Client HeartCore Enterprises, Inc. Announces Closing of $15.0 Million Nasdaq IPO

Boustead Client HeartCore Enterprises, Inc. ("HTCR") Announces Pricing of $15.0 Million IPO